Hjem › Blærekreft › Montana › Great Falls
Kliniske studier for Blærekreft i Great Falls, MT
5 studier for Blærekreft søker deltakere på steder i og rundt Great Falls (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekruttererFase 2
- Benefis Sletten Cancer Institute, Great Falls
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Benefis Sletten Cancer Institute, Great Falls
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- Benefis Sletten Cancer Institute, Great Falls
- Great Falls Clinic, Great Falls
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
Andre studier i Great Falls
- Prostatakreft10 studier
- Ikke-småcellet lungekreft9 studier
- Lungekreft9 studier
- Akut myelogen leukemi6 studier
- Kolorektal kreft5 studier
- Plateepitelcancer i hode og hals5 studier
- Melanom5 studier
- Brystkreft5 studier
- Tykktarmskreft4 studier
- Endometriekreft3 studier
- Nyrekreft (nyrecellekarcinom)3 studier
- Hypofarynxcancer3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.